Bryan Giraudo

Insider Reports History

Entity
Individual
Location
7707 Gateway Boulevard, Suite 140, Newark, CA
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bryan Giraudo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gossamer Bio, Inc. COO/CFO Common Stock 480K $284K $0.59 Jun 18, 2024 By family trust
Gossamer Bio, Inc. COO/CFO Stock Option (Right to Buy) 544K Jan 2, 2024 Direct
Protagonist Therapeutics, Inc Director Stock Option (right to buy) 25.7K Jan 2, 2024 Direct

Insider Reports Filed by Bryan Giraudo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GOSS Gossamer Bio, Inc. Jun 18, 2024 1 $59.1K 4 Jun 20, 2024 COO/CFO
GOSS Gossamer Bio, Inc. Mar 27, 2024 1 -$7.43K 4 Mar 28, 2024 COO/CFO
PTGX Protagonist Therapeutics, Inc Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
GOSS Gossamer Bio, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 COO/CFO
GOSS Gossamer Bio, Inc. Nov 20, 2023 1 $0 4 Nov 22, 2023 COO/CFO
GOSS Gossamer Bio, Inc. Nov 13, 2023 1 $113K 4 Nov 14, 2023 COO/CFO
GOSS Gossamer Bio, Inc. Jul 24, 2023 2 $100K 4 Jul 26, 2023 COO/CFO
GOSS Gossamer Bio, Inc. May 5, 2023 10 $0 4 May 9, 2023 COO/CFO
GOSS Gossamer Bio, Inc. Apr 4, 2023 1 $56.1K 4 Apr 5, 2023 COO/CFO
GOSS Gossamer Bio, Inc. Mar 20, 2023 2 $48.4K 4 Mar 22, 2023 COO/CFO
PTGX Protagonist Therapeutics, Inc Jan 16, 2023 1 $0 4 Jan 18, 2023 Director
GOSS Gossamer Bio, Inc. Dec 7, 2022 1 $0 4 Dec 9, 2022 COO/CFO
GOSS Gossamer Bio, Inc. Jul 15, 2022 1 $100K 4 Jul 15, 2022 COO/CFO
PTGX Protagonist Therapeutics, Inc May 26, 2022 1 $0 4 May 27, 2022 Director
GOSS Gossamer Bio, Inc. Mar 23, 2022 1 -$95.6K 4 Mar 24, 2022 COO/CFO
GOSS Gossamer Bio, Inc. Jan 6, 2022 1 $0 4 Jan 10, 2022 COO/CFO
GOSS Gossamer Bio, Inc. Sep 16, 2021 1 $0 4 Sep 20, 2021 COO/CFO
PTGX Protagonist Therapeutics, Inc May 27, 2021 1 $0 4 May 28, 2021 Director